| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $19.0M | +31.6% |
| SG&A Expense | $11.5M | +37.6% |
| Operating Income | -$30.6M | -33.4% |
| Income Tax | $0 | — |
| Net Income | -$29.0M | -82.6% |
| EPS (Basic) | -$1.01 | -71.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.1M | -39.1% |
| Current Assets | $45.6M | -37.1% |
| Total Assets | $57.4M | -31.7% |
| Current Liabilities | $4.8M | +33.0% |
| Total Liabilities | $5.2M | +2.6% |
| Stockholders' Equity | $52.2M | -33.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.6M | -45.8% |
| Capital Expenditures | $67K | +252.6% |
| Investing Cash Flow | -$67K | -252.6% |
| Financing Cash Flow | -$23K | -100.0% |
| Free Cash Flow | -$27.7M | -46.1% |